The Faces of Luminex: Robin Murphy, Systems Integration

January 17th, 2020 / Christina Olivas

The Luminex R&D teams for hardware, software, reagents, and assays operate mostly independently—which means we need great scientists to pull each of these elements together and ensure a seamless user experience. For this, we rely on Robin Murphy, Scientist II, who has been part of our family since 2006. He earned a bachelor’s in chemistry

Continue reading »

METHODS Special Issue: Multiplexing Protocol for Evaluating Biological Interactions with Nanoparticles

January 14th, 2020 / Hilary Graham

A new multiplexing protocol offers guidelines for measuring immunomodulatory effects of nanoparticles used in clinical applications Nanoparticles have the potential to deliver more targeted therapies to the exact location in the body where they’re most needed. To do this, it is essential to understand how these foreign particles interact with a patient’s body. A recent

Continue reading »

The Faces of Luminex: Martin Kochanczyk, Advanced Technologies Group

January 10th, 2020 / Christina Olivas

Our advanced technologies team is tasked with a mission that’s both challenging and fun: keeping Luminex at the cutting edge by figuring out what will be needed in the coming years and developing technology solutions to meet those needs. Physicist Martin Kochanczyk, Senior Manager of Technology Development, is one of the team members responsible for

Continue reading »

METHODS Special Issue: Multiplexing for Personalized Oncology

December 30th, 2019 / Hilary Graham

Assays quantify RNA expression even in challenging samples Multiplex molecular assays have several important roles in the realm of personalized cancer medicine. A team of researchers at the University of Malta recently published a paper, titled “Bead-based RNA multiplex panels for biomarker detection in oncology samples,” in the Methods journal that offers an overview of

Continue reading »

The Faces of Luminex: Brian Walsh, Technical Applications

December 20th, 2019 / Christina Olivas

We work hard to deliver robust systems and consumables to our customers, but even with the best quality control, occasional hiccups are unavoidable. That’s why we count on Brian Walsh, Technical Applications Specialist, to work closely with our customers and address any issues they may encounter. He joined Luminex in 2018, and holds a PhD

Continue reading »

METHODS Special Issue: Multiplexing to Quantify Cytokines and Chemokines in Mouse Brain Study

December 16th, 2019 / Hilary Graham

Assay requires minimal sample volume for 33-analyte interrogation Scientists from the National Institute of Neurological Disorders and Stroke and Bio-Rad Laboratories published a helpful protocol for a method to analyze more than 30 cytokines and chemokines in mouse brain tissue. The technique can be adapted to other sample types as well. The paper, titled “Method

Continue reading »

The Faces of Luminex: Yetzielisse Urgelles, Graphic Design

December 6th, 2019 / Christina Olivas

Whether it’s through our website, social media channels, or a conference booth, if you’ve seen Luminex content lately, then you’re already familiar with our talented creative services team. Today, we’re shining the spotlight on Yetzielisse Urgelles, a gifted graphic designer who joined our team in early 2018 after completing her BFA in graphic and web

Continue reading »

METHODS Special Issue: Clinical and Analytical Performance Data for NxTAG RPP

December 4th, 2019 / Hilary Graham

Highly scalable, multiplex molecular assay is comparable to xTAG RVP performance If you’ve ever used an assay based on xTAG® Technology, you may wonder how the newer NxTAG® Chemistry stacks up. A new publication in Methods uses clinical and analytical data from respiratory pathogen panels to demonstrate how both performance and workflow have improved with

Continue reading »

METHODS Special Issue: New Multiplex Assay for Vaccine Immunogenicity Testing

November 25th, 2019 / Hilary Graham

Recently developed test lowers cost and reduces sample volumes needed for evaluating combination vaccines Scientists at the Serum Institute of India have developed a new multiplex immunoassay to perform the mouse immunogenicity testing recommended in many countries for quality control in the production of combination vaccines. They chose xMAP® Technology to design the serological assay,

Continue reading »

The Faces of Luminex: Brett Osburn, Manufacturing

November 22nd, 2019 / Christina Olivas

Here at Luminex, we’re proud to design and manufacture the products we sell—whether we’re synthesizing dyes for multiplexing or building clinical assays. In our synthesis group, we count on Brett Osburn, Lead Manufacturing Chemist, to help ensure the quality of our products. He has two bachelor’s degrees: one in chemical engineering from Texas Tech University,

Continue reading »